GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Mani Inc (OTCPK:MNICF) » Definitions » Research & Development

Mani (MNICF) Research & Development : $0.0 Mil (TTM As of Aug. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Mani Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Mani's Research & Development for the three months ended in Aug. 2024 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Aug. 2024 was $0.0 Mil.

Mani Research & Development Historical Data

The historical data trend for Mani's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mani Research & Development Chart

Mani Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Mani Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Mani Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mani  (OTCPK:MNICF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Mani Research & Development Related Terms

Thank you for viewing the detailed overview of Mani's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Mani Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Mani Inc (OTCPK:MNICF) » Definitions » Research & Development
Comparable Companies
TSE:7817 TSE:3046 TSE:3593 TSE:7780 TSE:7716 TSE:3360 TSE:7979 TSE:8086 TSE:262A TSE:197A ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XSWX:STMN XPAR:DIM
Traded in Other Exchanges
7730:Japan
Address
8-3 Kogyodanchi, Tochigi, JPN
Website
http://www.mani.co.jp
Mani Inc manufactures medical devices and dental instruments. It sells products in four categories: surgical instruments, ophthalmic instruments, suture needles, and dental instruments. Mani's surgical products include instruments such as staplers, vessel knives, and bone saws. Its ophthalmic instruments include a range of knives used during eye surgery and ophthalmic sutures. Mani's suture needles business includes a variety of taper point and cutting eyeless needles, which require suture attachment and sterilization by the customer, as well as stainless-steel eyed needles. The firm's dental instruments include endodontic instruments and accessories, root canal equipment, and finishing and polishing instruments.

Mani Headlines

From GuruFocus

Hennessy Japan Fund Top Q3 Stock Adds and Reductions

By Holly LaFon Holly LaFon • 10-04-2014